# Patent Granted: Europe Just Said Yes to SJP-002C | Sen-Jam Pharmaceutical

- Canonical URL: https://wefunder.com/feed/299964
- Entity ID: wefunder:feed_item:299964
- Published at: 2026-04-14 13:43:52 UTC
- Updated at: 2026-04-21 08:58:30 UTC

## Author
Jim Iversen

## Subject
Sen-Jam Pharmaceutical

## Content
Dear Sen-Jam Investors & Community,Quick but important update: On March 25th, the European Patent Office granted our patent for SJP-002C for upper respiratory infections, including COVID-19.Here's why that matters:• IP protection now enforceable across 24 European member states (Austria, Belgium, Bulgaria, Germany, Denmark, Estonia, Finland, France, Great Britain, Italy, Lithuania, Luxembourg, Latvia, Malta, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Switzerland, Slovenia and Turkey.)• Strengthens licensing and partnership leverage internationally• Adds to a global patent estate of 70+ patents in 30 countries• Lands while SJP-002C is CMC-complete and Phase 2b/3 readyEvery milestone we hit de-risks this platform and increases its enterprise value. A European patent grant on our respiratory asset — backed by Phase 2 clinical data and a manufactured, FDA-ready drug product — is exactly the kind of convergence that gets noticed in licensing conversations.Thank you for being part of this journey. We're building something so special, and it is becoming more real everyday.With gratitude,Jim